Treatment Modalities for Graves’ Ophthalmopathy: Systematic Review and Metaanalysis-Reference-Cited by-同舟云学术

Treatment Modalities for Graves’ Ophthalmopathy: Systematic Review and Metaanalysis

Published:2009-08-01 Issue:8 Volume:94 Page:2708-2716
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Stiebel-Kalish Hadas¹²³,Robenshtok Eyal⁴⁵³,Hasanreisoglu Murat²,Ezrachi David²³,Shimon Ilan⁵³,Leibovici Leonard⁴³

Affiliation:

1. Neuroophthalmology Unit (H.S.-K.), Rabin Medical Center, Petah Tikva 49100, Israel

2. Ophthalmology (H.S.-K., M.H., D.E.), Rabin Medical Center, Petah Tikva 49100, Israel

3. Sackler School of Medicine (H.S.-K., E.R., D.E., I.S., L.L.), Tel Aviv University, Tel Aviv 69978, Israel

4. Departments of Medicine E (E.R., L.L.), Rabin Medical Center, Petah Tikva 49100, Israel

5. Institute of Endocrinology and Metabolism (E.R., I.S.), Rabin Medical Center, Petah Tikva 49100, Israel

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/94/8/2708/9063743/jcem2708.pdf

Reference60 articles.

1. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management.;Burch;Endocr Rev,1993

2. Untreated Graves’ disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.;Villadolid;J Clin Endocrinol Metab,1995

3. Ultrasonographic evidence of a consistent orbital involvement in Graves’ disease.;Werner;N Engl J Med,1974

4. Quality of life in patients with Graves’ ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument.;Gerding;Thyroid,1997

5. A questionnaire survey on the management of Graves’ orbitopathy in Europe.;Perros;Eur J Endocrinol,2006

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy for Refractory, Corticosteroid-Resistant Orbital Inflammatory Diseases: Plan Design, Clinical Efficacy, and Prognosis/Outcomes;2024-07-18

2. Tocilizumab use for optic nerve compression in thyroid eye disease: a prospective longitudinal cohort;International Ophthalmology;2024-05-08

3. The changing landscape of thyroid eye disease: current clinical advances and future outlook;Eye;2024-02-19

4. Safety of non-standard regimen of systemic steroid therapy in patients with Graves’ orbitopathy: a single-centre experience;Pharmacological Reports;2024-01-26

5. Teprotumumab in thyroid eye disease;Saudi Journal of Ophthalmology;2024-01